812.21
CH-JU
CH-JU
Art. 14 Loi sur la vente des médicaments
8. Santé, travail, sécurité sociale » 81. Santé » 812. Substances thérapeutiques, stupéfiants et poisons
Art. 14 Loi sur la vente des médicaments
1 Les médecins qui désirent exploiter une pharmacie privée selon l’article 8 doivent, dans les six mois qui suivent l’entrée en vigueur de la présente loi, demander une autorisation.
2 Les médecins qui n’obtiennent pas cette autorisation ont le droit d’exploiter leur pharmacie privée pendant trois ans au maximum dès l’entrée en vigueur du refus.
3 Les personnes autorisées à tenir un dépôt de médicaments selon l’ancien droit disposent d’un délai d’une année dès l’entrée en vigueur de la présente loi pour cesser leur exploitation.
Décisions judiciaires appliquant cette disposition (13)
VPB 08-1321-6731 (Art. 14, al. 3, LPTh)
Swiss Approval of Foreign-Approved Products
This article is cited in the context of a proposed abrogation to allow for simplified authorization procedures for importing patented medicines when patent protection is of lesser importance.
C-3334/2020 (Art. 14 Abs. 1 Bst. aquater HMG)
Homeopathic Medicine Simplified Approval Dispute
Cited as the basis for the simplified drug approval procedure, which was the subject of the original application.
A-3621/2014 (Art. 14 al. 1 let. a LPTh)
Pharmaceutical Product Approval Document Access Dispute
Cited in relation to simplified authorization procedures.
C-6960/2013 (Art. 14 Abs. 1 Bst. b HMG)
Regulatory Agency Reclassifies Plant-Derived Drugs
Cited in conjunction with the KPAV to justify the classification of the products and the limitation of economic freedom.
C-4776/2010 (Art. 14 HMG)
E.________-_______ Generic Drug Marketing Authorization Rejection Upheld
Cited as the provision for simplified approval procedures for medicinal products with known active ingredients, which was relevant to the discussion of generic drugs.
RR.2011.299 (Art. 14 Abs. 2 HMG)
Switzerland v. Germany: Cross-Border Evidence Sharing and Data Privacy in Contraceptive Case
Permits the import of a medicinal product into Switzerland, provided it is already authorized in Switzerland and imported from a country with an equivalent authorization system, under certain conditions.
C-7594/2008 (Art. 14 cpv. 1 lett. a LATer)
Marketing Authorization Appeal for Carbon Dioxide Local Anesthetic
Cited again in the context of the simplified approval procedure, subject to quality, safety, and efficacy requirements.
C-7594/2008 (Art. 14 cpv. 1 lett. a LATer)
Marketing Authorization Appeal for Carbon Dioxide Local Anesthetic
Cited as a basis for the possibility of a simplified approval procedure for known active ingredients.
36.2011.49 · ti (Art. 14 cpv. 1 lett. f LATer)
Health Insurance Reimbursement for Off-Label Psoriatic Arthritis Medication
Cited in the context of evaluating orphan drugs, noting that high therapeutic utility is not explicitly required for authorization under this specific clause.
C-2251/2006 (Art. 14 Abs. 2 HMG)
Patented Formulation Blocks Parallel Import of Medicine
Allows for simplified approval of parallel imports under certain conditions.
C-2251/2006 (Art. 14 Abs. 3 HMG)
Patented Formulation Blocks Parallel Import of Medicine
Prohibits the approval of parallel imports as long as the originator product is patent-protected.
VPB 06-2701-2245 (Art. 14, al. 1, let. d LPTh)
Swiss Drug Shortage Mitigation Act
This article is to be supplemented to allow for simplified authorization of radiopharmaceutical products, recognizing their specific nature and supply challenges in hospitals.
VPB 07-0197-2275 (Art. 14 al. 1 let. d LPTh)
Therapeutic Products Act Amendment: Medication Authorization and Exceptions
Defines simplified authorization procedures for certain drugs, including those manufactured by hospital pharmacies for hospital needs.